Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec Stranahan, an analyst at Bank of America Securities, maintained a Hold rating on ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Medicare is launching a new pilot program that will require prior approval for 17 health services using artificial intelligence tools. The Wasteful and Inappropriate Service Reduction (WISeR) model is ...

'Everything I own is gone': 77-year-old veteran loses everything in Cincinnati fire After two days recovering at UC Medical Center, Jim returned home to find his roof collapsed, the camper gone, and ...

The second-largest county in the United States has established a permanent guaranteed basic income program after the success of a previous pilot version. The Cook County Board of Commissioners ...

China’s increasing economic footprint in Brazil, Latin America’s largest economy, is redefining the region’s balance of power. Once primarily a trading partner, China is now entrenching itself in the ...

Every year, millions of U.S. households rely on a federally funded program to help pay their home heating bills. While benefits usually kick in on Nov. 1, because of the ongoing government shut down ...

An Adelphi University student is suing the school after it accused him of using artificial intelligence to write an essay deemed “too advanced” for a first-year student — a charge he calls “completely ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...